Statistics
Publications
64
Citations
5K
H-Index
30
Active since
2014
Mehdi Touat is an author at Sorbonne Université specializing in oncology, medicine, and molecular oncology.
Publications per year
2014–2025
64
64
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma
Ingo K. Mellinghoff, Martin J. van den Bent, Deborah T. Blumenthal et al. · New England Journal of Medicine · 2023 · 719 citations · Full text
Mechanisms and therapeutic implications of hypermutation in gliomas
Mehdi Touat, Yvonne Y. Li, Adam N. Boynton et al. · Nature · 2020 · 702 citations · Full text
Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer
Mehdi Touat, Thierry Maisonobe, Omar Ben Hadj Salem et al. · Neurology · 2018 · 330 citations
Life Sciences, Immunology, Pathology +17
Ivosidenib in Isocitrate Dehydrogenase 1<i>–</i>Mutated Advanced Glioma
Ingo K. Mellinghoff, Benjamin M. Ellingson, Mehdi Touat et al. · Journal of Clinical Oncology · 2020 · 307 citations · Full text
Medicine, Oncology, Pharmacology +16
1–5 of 64